Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Gut Microbiome Remodelling Reduces Neuroinflammation in TBI
March 2026
Antibiotic-treated mice demonstrated significantly smaller lesion volumes and reduced cell death compared with vehicle-treated controls after repeated injury.
Read more
5 Mar 2026
Gut Microbiome Remodelling Reduces Neuroinflammation in TBI
Antibiotic-treated mice demonstrated significantly smaller lesion volumes and reduced cell death compared with vehicle-treated controls after repeated injury.
4 Mar 2026
Trial Evaluates Lithium Treatment in Mild Cognitive Impairment
Low dose lithium treatment tested in mild cognitive impairment, offering effect size data for future larger trials.
4 Mar 2026
AI Model Could Streamline Cervical Spondylosis Diagnosis
New deep learning model combining X-ray and MRI data shows promise in increasing efficiency of cervical spondylosis diagnosis.
3 Mar 2026
Major Depressive Disorder: Biomarkers in Brain and Blood Identified
Shared molecular changes in brain and blood may improve major depressive disorder diagnosis and guide personalised therapies.
2 Mar 2026
Does Smoking Lower Parkinson’s Disease Risk?
A large cohort study links smoking habits to Parkinson’s disease risk and all-cause mortality, showing persistent smokers have lower PD risk but quitting improves survival.
28 Feb 2026
New Trial Targets Sensory Loss in Dementia Care
A pilot cluster randomised study in Ireland shows structured sensory intervention is feasible in dementia care, with strong staff engagement and device uptake.
27 Feb 2026
Blood Test Could Predict Alzheimer’s Disease Onset
The authors concluded that the time until onset of Alzheimer’s disease symptoms could be estimated using a single blood test within a margin of error that may be acceptable for use in clinical trials.
24 Feb 2026
Five Year Outcomes of Ublituximab in Multiple Sclerosis
Long-term ublituximab treatment reduces relapse rates and disability progression, reinforcing early intervention strategies in multiple sclerosis care.
Loading posts...
1
2
3
…
57
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View